The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup studyK B Miller, M J O'Connell, K. Kyungmann et al.|Annals of Hematology|1992Cited by 116
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup studyK B Miller, M J O'Connell, Richard S. Neiman et al.|Annals of Hematology|1993Cited by 115
Reproducibility of the French‐American‐British classification of acute Leukemia: The southwest oncology group experienceDavid R. Head, John J. Hutton, Richard A. Savage et al.|American Journal of Hematology|1985Cited by 40
Institutional performance in application of the FAB classification of acute leukemia. The southwest oncology group experienceDavid R. Head, John J. Hutton, Catherine Craven et al.|Cancer|1985Cited by 27
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An eastern cooperative oncology group/southwest oncology group cooperative studyDavid R. Head, Michael R. Grever, Kenneth J. Kopecky et al.|Cancer|1989Cited by 17